{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:48:59Z","timestamp":1787168939371,"version":"build-2736575974"},"reference-count":37,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2005,1,1]],"date-time":"2005-01-01T00:00:00Z","timestamp":1104537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,1,1]],"date-time":"2005-01-01T00:00:00Z","timestamp":1104537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy Research"],"published-print":{"date-parts":[[2005,1]]},"DOI":"10.1016\/j.eplepsyres.2004.10.002","type":"journal-article","created":{"date-parts":[[2004,12,16]],"date-time":"2004-12-16T08:07:31Z","timestamp":1103184451000},"page":"17-25","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":117,"title":["Effects of the antiepileptic drugs lamotrigine, topiramate and gabapentin on hERG potassium currents"],"prefix":"10.1016","volume":"63","author":[{"given":"Bengt R.","family":"Danielsson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"Lansdell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie","family":"Patmore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torbj\u00f6rn","family":"Tomson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eplepsyres.2004.10.002_bib1","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1053\/seiz.1999.0306","article-title":"SUDEP overview of definitions and review of incidence data","volume":"8","author":"Annegers","year":"1999","journal-title":"Seizure"},{"key":"10.1016\/j.eplepsyres.2004.10.002_bib2","series-title":"Medical Risks in Epilepsy","first-page":"79","article-title":"Fatal adverse reactions to antiepileptic drugs, as seen in a spontaneous reporting system","author":"Askmark","year":"2001"},{"key":"10.1016\/j.eplepsyres.2004.10.002_bib3","unstructured":"Canadian Minister of Health, 2001. Therapeutic Products Directorate Guidance Document: Assessment of the QT Prolongation Potential of Non-antiarhytmic Drugs. Canadian Minister of Health. Ref Type: Internet Communication."},{"key":"10.1016\/j.eplepsyres.2004.10.002_bib4","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/0092-8674(95)90358-5","article-title":"A molecular basis for cardiac arrhythmia: hERG mutations cause long QT syndrome","volume":"80","author":"Curran","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.eplepsyres.2004.10.002_bib5","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0920-1211(03)00119-0","article-title":"Phenytoin and phenobarbital inhibit human hERG potassium channels","volume":"55","author":"Danielsson","year":"2003","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2004.10.002_bib6","unstructured":"EMEA, 1997. Points to Consider: The Assessment of the Potential for QT Interval Prolongation by Non-Cardivascular Medicinal Products (EMEACPMP\/986\/96). Internet."},{"key":"10.1016\/j.eplepsyres.2004.10.002_bib7","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1212\/WNL.51.5.1270","article-title":"Population-based study of the incidence of sudden unexplained death in epilepsy","volume":"51","author":"Ficker","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.eplepsyres.2004.10.002_bib8","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1159\/000026528","article-title":"Modulation of calcium and potassium currents by lamotrigine","volume":"38","author":"Grunze","year":"1998","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.eplepsyres.2004.10.002_bib9","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S0140-6736(05)73573-X","article-title":"Psychotropic drugs, hERG, and the heart","volume":"356","author":"Hancox","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.eplepsyres.2004.10.002_bib10","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1111\/j.0013-9580.2004.58403.x","article-title":"Inhibitory effect of lamotrigine on A-type potassium current in hippocampal neuron-derived H19-7 cells","volume":"45","author":"Hunag","year":"2004","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2004.10.002_bib11","unstructured":"ICH, 2003. ICHS7B: Nonclinical Studies for Assessing Risk of Cardiac Arrhythmia Associated with Delayed Ventricular Repolarization (QT Interval Prolongation) for Human Pharmaceuticals. Step 2. Ref Type: Internet Communication."},{"key":"10.1016\/j.eplepsyres.2004.10.002_bib12","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/00007691-200306000-00016","article-title":"Therapeutic drug monitoring of the newer antiepileptic drugs","volume":"25","author":"Johannessen","year":"2003","journal-title":"Ther. Drug Monitor."},{"key":"10.1016\/j.eplepsyres.2004.10.002_bib13","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1136\/jnnp.68.2.211","article-title":"Sudden unexpected death in epilepsy: a series of witnessed deaths","volume":"68","author":"Langan","year":"2000","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.eplepsyres.2004.10.002_bib14","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1528-1157.1997.tb01076.x","article-title":"Sudden unexplained death in epilepsy: observations from a large clinical development program","volume":"38","author":"Leestma","year":"1997","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2004.10.002_bib15","doi-asserted-by":"crossref","first-page":"323","DOI":"10.2165\/00002018-200124050-00001","article-title":"Evaluation of drug-induced QT interval prolongation: implications for drug approval and labelling","volume":"24","author":"Malik","year":"2001","journal-title":"Drug Saf."},{"key":"10.1016\/j.eplepsyres.2004.10.002_bib16","first-page":"H2534","article-title":"Blockage of the hERG human cardiac K+ channel by the gastrointestinal prokinetic agent cisapride","volume":"273","author":"Mohammad","year":"1997","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.eplepsyres.2004.10.002_bib17","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1136\/jnnp.60.3.297","article-title":"Apnoea and bradycardia during epileptic seizures: relation to sudden death in epilepsy","volume":"60","author":"Nashef","year":"1996","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.eplepsyres.2004.10.002_bib18","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1046\/j.1528-1157.2001.22000.x","article-title":"Antiepileptic drug therapy and its management in sudden unexpected death in epilepsy: a case\u2013control study","volume":"42","author":"Nilsson","year":"2001","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2004.10.002_bib19","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/S0140-6736(98)05114-9","article-title":"Risk factors for sudden unexpected death in epilepsy: a case\u2013control study","volume":"353","author":"Nilsson","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.eplepsyres.2004.10.002_bib20","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1054\/jocn.1999.0137","article-title":"Sudden unexpected death in epilepsy in Victoria","volume":"7","author":"Opeskin","year":"2000","journal-title":"J. Clin. Neurosci."},{"key":"10.1016\/j.eplepsyres.2004.10.002_bib21","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1056\/NEJM197710132971502","article-title":"Natural history of lactic acidosis after grand-mal seizures. A model for the study of an anion-gap acidosis not associated with hyperkalemia","volume":"297","author":"Orringer","year":"1977","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.eplepsyres.2004.10.002_bib22","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1016\/S0140-6736(02)08726-3","article-title":"Sudden death in epilepsy: a wake-up call for management","volume":"359","author":"Pedley","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.eplepsyres.2004.10.002_bib23","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1520\/JFS14634J","article-title":"Postmortem investigation of lamotrigine concentrations","volume":"45","author":"Pricone","year":"2000","journal-title":"J. Forensic Sci."},{"key":"10.1016\/j.eplepsyres.2004.10.002_bib24","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1212\/WNL.56.4.514","article-title":"Mortality in antiepileptic drug programs","volume":"56","author":"Racoosin","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.eplepsyres.2004.10.002_bib25","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0008-6363(02)00846-5","article-title":"Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs; evidence for a provisional safety margin in drug development","volume":"58","author":"Redfern","year":"2003","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.eplepsyres.2004.10.002_bib26","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1528-1157.1995.tb01661.x","article-title":"Cohort study of incidence of sudden unexplained death in persons with seizure disorder treated with antiepileptic drugs in Saskatchewan, Canada","volume":"36","author":"Tennis","year":"1995","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2004.10.002_bib27","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1046\/j.1365-2990.2003.00452.x","article-title":"Sudden unexpected death in epilepsy (SUDEP): evidence of acute neuronal injury using HSP-70 and c-Jun immunohistochemistry","volume":"29","author":"Thom","year":"2003","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.eplepsyres.2004.10.002_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.eplepsyres.2004.05.004","article-title":"Medical risks in epilepsy: a review with focus on physical injuries, mortality, traffic accidents and their prevention","volume":"60","author":"Tomson","year":"2004","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2004.10.002_bib29","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1126\/science.7604285","article-title":"hERG, a human inward rectifier in the voltage-gated potassium channel family","volume":"269","author":"Trudeau","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.eplepsyres.2004.10.002_bib30","first-page":"739","article-title":"The effect of external pH on the delayed rectifying K+ current in cardiac ventricular myocytes","volume":"439","author":"Vereecke","year":"2000","journal-title":"Pflugers Arch."},{"key":"10.1016\/j.eplepsyres.2004.10.002_bib31","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1016\/S0140-6736(99)02107-8","article-title":"Long QT syndromes and torsade de pointes","volume":"354","author":"Viskin","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.eplepsyres.2004.10.002_bib32","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1212\/WNL.56.4.519","article-title":"Incidence and risk factors in sudden unexpected death in epilepsy: a prospective cohort study","volume":"56","author":"Walczak","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.eplepsyres.2004.10.002_bib33","doi-asserted-by":"crossref","first-page":"673","DOI":"10.2165\/00002018-200326100-00001","article-title":"Do antiepileptic drugs play a role in suddden unexpected death in epilepsy?","volume":"26","author":"Walczak","year":"2003","journal-title":"Drug Saf."},{"key":"10.1016\/j.eplepsyres.2004.10.002_bib34","first-page":"116","article-title":"Towards a drug concentration effect relationship for QT prolongation and torsades de point","volume":"1","author":"Webster","year":"2002","journal-title":"Curr. Opin. Drug Discovery Dev."},{"key":"10.1016\/j.eplepsyres.2004.10.002_bib35","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1046\/j.1440-1681.2000.03337.x","article-title":"Familial and acquired long qt syndrome and the cardiac rapid delayed rectifier potassium current","volume":"27","author":"Witchel","year":"2000","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.eplepsyres.2004.10.002_bib36","first-page":"237","article-title":"Adverse event monitoring in lamotrigine patients: a pharmacoepidemiologic study in the United Kingdom","volume":"42","author":"Wong","year":"2001","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2004.10.002_bib37","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S0006-3495(98)77782-3","article-title":"Properties of hERG channels stably expressed in HEK 293 cells studied at physiological temperature","volume":"74","author":"Zhou","year":"1998","journal-title":"Biophys. J."}],"container-title":["Epilepsy Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121104002190?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121104002190?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T13:14:07Z","timestamp":1760274847000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920121104002190"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,1]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,1]]}},"alternative-id":["S0920121104002190"],"URL":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2004.10.002","relation":{},"ISSN":["0920-1211"],"issn-type":[{"value":"0920-1211","type":"print"}],"subject":[],"published":{"date-parts":[[2005,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of the antiepileptic drugs lamotrigine, topiramate and gabapentin on hERG potassium currents","name":"articletitle","label":"Article Title"},{"value":"Epilepsy Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2004.10.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}